Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Joint Bone Spine|February 2, 2024
VEXAS syndrome: An updateMohamed-Yacine Khitri, Jérôme Hadjadj, Arsène Mekinian, et al.Annals of Hematology|August 10, 2018
Autoimmune manifestations associated with myelodysplastic syndromesEric Grignano, Vincent Jachiet, Pierre Fenaux, et al.Neurocritical Care|July 20, 2016
Acute Respiratory Failure in a Patient with Stiff-Person SyndromeVincent Jachiet, Laurent Laine, Thierry Gendre, et al.La Revue Du Praticien|June 6, 2025
[VEXAS Syndrome]Vincent Jachiet, Thibault Comont, Olivier Kosmider, et al.Bulletin Du Cancer|July 6, 2023
[Dysimmune manifestations associated with myelodysplastic neoplasms and chronic myelomonocytic leukaemias]Vincent Jachiet, Jérôme Hadjadj, Lin-Pierre Zhao, et al.JACC. Case Reports|July 28, 2021
Acute Myocarditis Revealing Adult-Onset Still's DiseaseRaphaël Cohen, Pascal Nhan, Clément Cholet, et al.Journal of Neurology|August 16, 2018
Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosisVincent Jachiet, Raphael Lhote, Pierre Rufat, et al.Annals of the Rheumatic Diseases|February 15, 2019
Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinibLaure Ricard, Vincent Jachiet, Florent Malard, et al.The Lancet. Rheumatology|September 7, 2025
Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for preventionValentine Ribier, Jérôme Hadjadj, Vincent Jachiet, et al.Clinical and Experimental Immunology|June 27, 2022
6-Sulfo LacNAc monocytes are quantitatively and functionally disturbed in systemic sclerosis patientsLaure Ricard, Déborah Eshagh, Lama Siblany, et al.Pageof 4